- 31 Downloads
Current strategies in pediatric oncology have utilized an approach which balances the probability of cure and risk of acute and late toxicity from treatment. This chapter will discuss some of the recent development in pediatric radiation oncology and explores the different strategies that have been utilized, Many of the strategies have decreased either dose or volume of radiotherapy; however, in certain scenarios, the role of radiotherapy has expanded to include treatment of young children < 3 years with brain tumors, treatment of metastatic disease as part of initial therapy and use of reirradiation.
- Casey DL, Friedman DN, Moskowitz CS et al (2014) Second cancer risk in childhood cancer survivors treated with intensity modulated radiation therapy (IMRT). Pediatr Blood Cancer 62:445–449Google Scholar
- Castellino S, Keller F, Voss S et al (2014) Outcomes and patterns of failure in children/adolescents with low-risk Hodgkin lymphoma (HL) who are FDG-PET (PET3) positive after AVPC therapy. Kin Padiatr 226:O-06 (abstract)Google Scholar
- Dix DB, Gratias EJ, Seibel N et al (2014) Treatment of stage IV favorable histology Wilms tumor with incomplete lung metastasis response after chemotherapy: a report from Children’s Oncology Group study AREN0533. J Clin Oncol 32:5s (abstr 10001)Google Scholar
- Douglas JG, Barker JL, Ellenbogen RG et al (2004) Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure. Int J Radiat Oncol Biol Phys 58:1161–1164CrossRefGoogle Scholar
- Friedman DL, Chen L, Wolden S et al (2014) Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly-diagnosed intermediate-risk Hodgkin lymphoma: a report from the Children’s Oncology Group study AHOD0031. J Clin Oncol 32:3651–3658CrossRefPubMedPubMedCentralGoogle Scholar
- Grundy PE, Green DM, Dirks AC et al (2012) Clinical significance of pulmonary nodules detected by CT and not CXR in patients treated for favorable histology Wilms tumor studies −4 and −5: a report from the Children’s Oncology Group. Pediatr Blood Cancer 59:631–635CrossRefPubMedPubMedCentralGoogle Scholar
- Merchant TE, Bendel AE, Sabin N et al (2015) A Phase II trial of conformal radiation therapy for pediatric patients with localized ependymoma, chemotherapy prior to second surgery for incompletely resected ependymoma and observation for completely resected, differentiated, supratentorial ependymoma. Int J Radiat Oncol 93(3S):S1 (abstract)Google Scholar
- Spunt SL, Million L, Anderson JR et al (2014) Risk-based treatment for Nonrhabdomyosarcoma soft tissue sarcomas (NRSTS) in patients under 30 years of age: Children’s Oncology Group study ARST0332. J Clin Oncol 23:5s (abstr 10008)Google Scholar
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 2.5 International License (http://creativecommons.org/licenses/by-nc/2.5/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.